Prolymphocytic Leukemia — Trials

Prolymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

95 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 11
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 25%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–25 of 25 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02005289	Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL	completed	Phase 2	41	Ohio State University Comprehensive Cancer CenterOTHER	1	Dec 15, 2025	clinicaltrials
NCT04191187	Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies	completed	Phase 2	34	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1